Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
World Health Organization Collaborating Centre for Global Women's Health Research, University of Birmingham, Birmingham, UK.
BJOG. 2021 Jul;128(8):1324-1333. doi: 10.1111/1471-0528.16658. Epub 2021 Mar 3.
To evaluate whether the implementation of the FAST-M complex intervention was feasible and improved the recognition and management of maternal sepsis in a low-resource setting.
A before-and-after design.
Fifteen government healthcare facilities in Malawi.
Women suspected of having maternal sepsis.
The FAST-M complex intervention consisted of the following components: the FAST-M maternal sepsis treatment bundle and the FAST-M implementation programme. Performance of selected process outcomes was compared between a 2-month baseline phase and 6-month intervention phase with compliance used as a proxy measure of feasibility.
Compliance with vital sign recording and use of the FAST-M maternal sepsis bundle.
Following implementation of the FAST-M intervention, women were more likely to have a complete set of vital signs taken on admission to the wards (0/163 [0%] versus 169/252 [67.1%], P < 0.001). Recognition of suspected maternal sepsis improved with more cases identified following the intervention (12/106 [11.3%] versus 107/166 [64.5%], P < 0.001). Sepsis management improved, with women more likely to receive all components of the FAST-M treatment bundle within 1 hour of recognition (0/12 [0%] versus 21/107 [19.6%], P = 0.091). In particular, women were more likely to receive antibiotics (3/12 [25.0%] versus 72/107 [67.3%], P = 0.004) within 1 hour of recognition of suspected sepsis.
Implementation of the FAST-M complex intervention was feasible and led to the improved recognition and management of suspected maternal sepsis in a low-resource setting such as Malawi.
Implementation of a sepsis care bundle for low-resources improved recognition & management of maternal sepsis.
评估 FAST-M 综合干预措施的实施是否可行,并改善资源匮乏环境下产妇脓毒症的识别和管理。
前后对照设计。
马拉维 15 家政府医疗机构。
疑似患有产妇脓毒症的妇女。
FAST-M 综合干预措施包括以下组成部分:FAST-M 产妇脓毒症治疗包和 FAST-M 实施计划。在 2 个月的基线期和 6 个月的干预期之间比较了选定的过程结果的表现,以依从性作为可行性的替代指标。
生命体征记录和使用 FAST-M 产妇脓毒症包的依从性。
实施 FAST-M 干预后,女性更有可能在入院时接受完整的一组生命体征检查(0/163 [0%] 与 169/252 [67.1%],P < 0.001)。疑似产妇脓毒症的识别率提高,干预后识别的病例更多(12/106 [11.3%] 与 107/166 [64.5%],P < 0.001)。脓毒症管理得到改善,女性更有可能在识别后 1 小时内接受 FAST-M 治疗包的所有组成部分(0/12 [0%] 与 21/107 [19.6%],P = 0.091)。特别是,女性更有可能在识别疑似脓毒症后 1 小时内接受抗生素治疗(3/12 [25.0%] 与 72/107 [67.3%],P = 0.004)。
在资源匮乏的环境中,如马拉维,实施 FAST-M 综合干预措施是可行的,并能改善疑似产妇脓毒症的识别和管理。
在资源匮乏的情况下实施脓毒症护理包可提高产妇脓毒症的识别和管理水平。